Stanford Stroke Center, Palo Alto, California.
Neurology Department, Hôpital Fondation A. de Rothschild, Paris, France.
JAMA Neurol. 2023 May 1;80(5):523-528. doi: 10.1001/jamaneurol.2023.0265.
The benefit of reperfusion therapies for acute ischemic stroke decreases over time. This decreasing benefit is presumably due to the disappearance of salvageable ischemic brain tissue (ie, the penumbra).
To study the association between stroke onset-to-imaging time and penumbral volume in patients with acute ischemic stroke with a large vessel occlusion.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective, multicenter, cross-sectional study was conducted from January 1, 2015, to June 30, 2022. To limit selection bias, patients were selected from (1) the prospective registries of 2 comprehensive centers with systematic use of magnetic resonance imaging (MRI) with perfusion, including both thrombectomy-treated and untreated patients, and (2) 1 prospective thrombectomy study in which MRI with perfusion was acquired per protocol but treatment decisions were made with clinicians blinded to the results. Consecutive patients with acute stroke with intracranial internal carotid artery or first segment of middle cerebral artery occlusion and adequate quality MRI, including perfusion, performed within 24 hours from known symptoms onset were included in the analysis.
Time from stroke symptom onset to baseline MRI.
Penumbral volume, measured using automated software, was defined as the volume of tissue with critical hypoperfusion (time to maximum >6 seconds) minus the volume of the ischemic core. Substantial penumbra was defined as greater than or equal to 15 mL and a mismatch ratio (time to maximum >6-second volume/core volume) greater than or equal to 1.8.
Of 940 patients screened, 516 were excluded (no MRI, n = 19; no perfusion imaging, n = 59; technically inadequate perfusion imaging, n = 75; second segment of the middle cerebral artery occlusion, n = 156; unwitnessed stroke onset, n = 207). Of 424 included patients, 226 (53.3%) were men, and mean (SD) age was 68.9 (15.1) years. Median onset-to-imaging time was 3.8 (IQR, 2.4-5.5) hours. Only 16 patients were admitted beyond 10 hours from symptom onset. Median core volume was 24 (IQR, 8-76) mL and median penumbral volume was 58 (IQR, 29-91) mL. An increment in onset-to-imaging time by 1 hour resulted in a decrease of 3.1 mL of penumbral volume (β coefficient = -3.1; 95% CI, -4.6 to -1.5; P < .001) and an increase of 3.0 mL of core volume (β coefficient = 3.0; 95% CI, 1.3-4.7; P < .001) after adjustment for confounders. The presence of a substantial penumbra ranged from approximately 80% in patients imaged at 1 hour to 70% at 5 hours, 60% at 10 hours, and 40% at 15 hours.
Time is associated with increasing core and decreasing penumbral volumes. Despite this, a substantial percentage of patients have notable penumbra in extended time windows; the findings of this study suggest that a large proportion of patients with large vessel occlusion may benefit from therapeutic interventions.
急性缺血性脑卒中的再灌注治疗的益处会随时间推移而降低。这种益处的降低可能是由于可挽救的缺血性脑组织(即半影区)消失所致。
研究急性大血管闭塞性脑卒中患者的发病至影像时间与半影区容积之间的关系。
设计、地点和参与者:这是一项回顾性、多中心、横断面研究,于 2015 年 1 月 1 日至 2022 年 6 月 30 日进行。为了限制选择偏倚,从(1)2 个综合中心的前瞻性登记处中选择患者,这些中心系统地使用包括血栓切除术治疗和未治疗患者在内的磁共振成像(MRI),以及(2)1 项前瞻性血栓切除术研究,该研究根据方案获取了灌注 MRI,但治疗决策由对结果不知情的临床医生做出。纳入分析的患者为急性脑卒中,颅内颈内动脉或大脑中动脉第一段闭塞,且有足够质量的 MRI,包括在已知症状发作后 24 小时内进行的灌注 MRI。
从脑卒中症状发作到基线 MRI 的时间。
使用自动软件测量半影区容积,定义为临界低灌注组织的体积(达最大时间>6 秒)减去缺血核心的体积。大面积半影区定义为大于或等于 15 mL 和错配比(达最大时间>6 秒的体积/核心体积)大于或等于 1.8。
在筛选的 940 名患者中,516 名被排除(无 MRI,n=19;无灌注成像,n=59;灌注成像技术不足,n=75;大脑中动脉第二段闭塞,n=156;无法证实的脑卒中发作,n=207)。在纳入的 424 名患者中,226 名(53.3%)为男性,平均(SD)年龄为 68.9(15.1)岁。中位发病至影像时间为 3.8(IQR,2.4-5.5)小时。仅有 16 名患者在症状发作后 10 小时内入院。中位核心容积为 24(IQR,8-76)mL,中位半影区容积为 58(IQR,29-91)mL。发病至影像时间每增加 1 小时,半影区容积减少 3.1 mL(β系数=-3.1;95%CI,-4.6 至-1.5;P<.001),核心容积增加 3.0 mL(β系数=3.0;95%CI,1.3-4.7;P<.001),校正混杂因素后。在 1 小时内进行成像的患者中,大面积半影区的存在率约为 80%,而在 5 小时、10 小时和 15 小时分别为 70%、60%和 40%。
时间与核心体积增加和半影区容积减少相关。尽管如此,在延长的时间窗口内,仍有相当比例的患者存在显著的半影区;这项研究的结果表明,大部分大血管闭塞患者可能受益于治疗干预。